gem·cit·a·bine

(jĕm-sī′tə-bēn′)

A nucleoside analog, C₉H₁₁F₂N₃O₄, used in its hydrochloride form in the treatment of pancreatic cancer and in combination with other drugs to treat breast, ovarian, and non-small cell lung cancer.

[gem-, perhaps shortening and alteration of CCRF-CEM, designation of the leukemia cell culture on which it was first tested + -citabine, nucleoside analog antiviral and anticancer drug suffix; see zalcitabine.]

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

References in periodicals archive

Gemcitabine hydrochloride was a gift sample from Emcure pharma Pvt Ltd.; corn starch soluble, polyvinyl alcohol, acetone, disodium hydrogen orthophosphate, and Sodium chloride were purchased from Central Drug House (P) Ltd., New Delhi.

Development and characterization of nanoparticles for the delivery of gemcitabine hydrochloride

16 November 2010 - US generic injectable pharmaceuticals maker Hospira Inc (NYSE: HSP) said yesterday it has launched a 2-gr vial of gemcitabine hydrochloride (HCL) for injection.

Hospira introduces gemcitabine for injection

INDIANAPOLIS -- A federal judge here has upheld Eli Lilly and Co.'s compound patent on Gemzar (gemcitabine hydrochloride for injection), maintaining the company's U.S.

Lilly's patent for Gemzar found valid

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.